Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019

D Singh, A Agusti, A Anzueto, PJ Barnes… - European …, 2019 - Eur Respiratory Soc
Precision medicine is a patient-specific approach that integrates all relevant clinical, genetic
and biological information in order to optimise the therapeutic benefit relative to the …

Minimal clinically important differences in pharmacological trials

PW Jones, KM Beeh, KR Chapman… - American journal of …, 2014 - atsjournals.org
The concept of a minimal clinically important difference (MCID) is well established. Here, we
review the evidence base and methods used to define MCIDs as well as their strengths and …

Global initiative for chronic obstructive lung disease 2023 report: GOLD executive summary

A Agustí, BR Celli, GJ Criner, D Halpin… - American journal of …, 2023 - atsjournals.org
The Global Initiative for Chronic Obstructive Lung Disease (GOLD) has published the
complete 2023 GOLD report, which can be freely downloaded from its web page (www …

Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary

CF Vogelmeier, GJ Criner, FJ Martinez… - American journal of …, 2017 - atsjournals.org
This Executive Summary of the Global Strategy for the Diagnosis, Management, and
Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 …

Dyspnoea: a multidimensional and multidisciplinary approach

L Laviolette, P Laveneziana - European Respiratory Journal, 2014 - Eur Respiratory Soc
Dyspnoea is a debilitating symptom that affects quality of life, exercise tolerance and
mortality in various disease conditions/states. In patients with chronic obstructive pulmonary …

A review of national guidelines for management of COPD in Europe

M Miravitlles, C Vogelmeier, N Roche… - European …, 2016 - Eur Respiratory Soc
The quality of care can be improved by the development and implementation of evidence-
based treatment guidelines. Different national guidelines for chronic obstructive pulmonary …

Leitlinie zur Diagnostik und Therapie von Patienten mit chronisch obstruktiver Bronchitis und Lungenemphysem (COPD)

C Vogelmeier, R Buhl, O Burghuber, CP Criée… - …, 2018 - thieme-connect.com
Das vorliegende Dokument ist eine Neufassung und Aktualisierung der Leitlinie zur
Diagnostik und Therapie von Patienten mit COPD, die die bisherige Version aus dem Jahr …

Хроническая обструктивная болезнь легких: федеральные клинические рекомендации по диагностике и лечению

АГ Чучалин, СН Авдеев, ЗР Айсанов… - …, 2022 - journal.pulmonology.ru
Аннотация В настоящее время хроническая обструктивная болезнь легких (ХОБЛ)
является глобальной проблемой и одной из ведущих причин смерти в мире. Терапия …

Dual combination therapy versus long‐acting bronchodilators alone for chronic obstructive pulmonary disease (COPD): a systematic review and network meta …

Y Oba, E Keeney, N Ghatehorde… - Cochrane Database of …, 2018 - cochranelibrary.com
Background Long‐acting bronchodilators such as long‐acting β‐agonist (LABA), long‐
acting muscarinic antagonist (LAMA), and LABA/inhaled corticosteroid (ICS) combinations …

Canadian Thoracic Society Clinical Practice Guideline on pharmacotherapy in patients with COPD–2019 update of evidence

J Bourbeau, M Bhutani, P Hernandez, SD Aaron… - 2019 - Taylor & Francis
In this guideline update, we highlight important and new findings related to pharmacological
therapy of chronic obstructive pulmonary disease (COPD) that should change clinical …